Tag: triphase accelerator corporation
Celgene Nabs Triphase’s Brain-Penetrant Proteasome Inhibitor for Oncology Drug Development
Celgene acquired Triphase Accelerator Corporation’s marine sourced proteasome inhibitor, marizomib (MRZ). The drug is being developed for treating patients with ...